Panobinostat

Panobinostat is a medication used to treat certain types of cancer, specifically multiple myeloma, which affects plasma cells in the bone marrow. It works by inhibiting enzymes called histone deacetylases (HDACs), which help control gene expression in cells. By blocking these enzymes, panobinostat can help promote the death of cancer cells and enhance the effectiveness of other cancer treatments. Typically, it is used in combination with other therapies when the disease is not responding to previous treatments. As with any medication, it can have side effects, so it's important for patients to discuss its use with their healthcare provider.